We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+9.91%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.1B
AUM Growth
+$73.5M
Cap. Flow
-$16.3M
Cap. Flow %
-1.48%
Top 10 Hldgs %
28.91%
Holding
248
New
4
Increased
56
Reduced
116
Closed
11

Top Buys

Rank Stock Value
1
ZBRA icon
Zebra Technologies
ZBRA
+$2.39M
2
ABBV icon
AbbVie
ABBV
+$1.05M
3
SYK icon
Stryker
SYK
+$910K
4
APD icon
Air Products & Chemicals
APD
+$856K
5
RLAY icon
Relay Therapeutics
RLAY
+$805K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.51M
2
MIDD icon
Middleby
MIDD
+$2.65M
3
MRSH
Marsh
MRSH
+$1.4M
4
AMZN icon
Amazon
AMZN
+$1.02M
5
AFL icon
Aflac
AFL
+$1M

Sector Composition

Rank Sector Weight
1 Technology 22.19%
2 Healthcare 16.25%
3 Financials 9.14%
4 Industrials 8.55%
5 Consumer Discretionary 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IVV icon
101
iShares Core S&P 500 ETF
IVV
$904B
$2M 0.18%
5,946
+341
+6% +$113K
GLNG icon
102
Golar LNG
GLNG
$5.13B
$1.91M 0.17%
316,149
-70,767
-18% -$633K
XOM icon
103
ExxonMobil
XOM
$634B
$1.84M 0.17%
53,699
-12,725
-19% -$520K
ALC icon
104
Alcon
ALC
$35B
$1.79M 0.16%
31,521
-2,195
-7% -$129K
MO icon
105
Altria Group
MO
$114B
$1.77M 0.16%
45,934
-2,905
-6% -$121K
ORCL icon
106
Oracle
ORCL
$423B
$1.77M 0.16%
29,630
-4,598
-13% -$261K
HUBB icon
107
Hubbell
HUBB
$27.2B
$1.77M 0.16%
12,910
-200
-2% -$27.5K
ADI icon
108
Analog Devices
ADI
$190B
$1.66M 0.15%
14,232
-129
-0.9% -$15.1K
RTX icon
109
RTX Corp
RTX
$301B
$1.66M 0.15%
28,821
-5,947
-17% -$362K
T icon
110
AT&T
T
$163B
$1.65M 0.15%
76,665
-107
-0.1% -$2.39K
DEO icon
111
Diageo
DEO
$53.6B
$1.64M 0.15%
11,939
+187
+2% +$25.8K
TT icon
112
Trane Technologies
TT
$106B
$1.63M 0.15%
13,480
-75
-0.6% -$8.42K
AXP icon
113
American Express
AXP
$230B
$1.62M 0.15%
16,125
-193
-1% -$19K
KMB icon
114
Kimberly-Clark
KMB
$36.5B
$1.61M 0.15%
10,884
– –
NVS icon
115
Novartis
NVS
$297B
$1.59M 0.14%
18,325
– –
HOLX
116
DELISTED
Hologic
HOLX
$1.54M 0.14%
23,145
-850
-4% -$53.8K
SPLK
117
DELISTED
Splunk Inc
SPLK
$1.49M 0.14%
7,915
+289
+4% +$57.6K
IBM icon
118
IBM
IBM
$224B
$1.45M 0.13%
12,432
-2,272
-15% -$267K
LLY icon
119
Eli Lilly
LLY
$1.06T
$1.44M 0.13%
9,715
-11
-0.1% -$1.7K
VV icon
120
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$1.42M 0.13%
9,047
-2
-0% -$308
LVGO
121
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$1.4M 0.13%
10,000
– –
ILMN icon
122
Illumina
ILMN
$28.4B
$1.39M 0.13%
4,637
-26
-0.6% -$8.96K
WELL icon
123
Welltower
WELL
$171B
$1.37M 0.12%
24,925
-2,141
-8% -$118K
GLW icon
124
Corning
GLW
$143B
$1.34M 0.12%
41,496
-1,906
-4% -$58.9K
MOAT icon
125
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$1.33M 0.12%
24,460
-595
-2% -$32.5K
3 4
5
6 7

Similar funds

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CPA
Capital Performance Advisors Walnut Creek, California $1.5B AUM 21.4% 1-Year Est. Return
MCM
Maple Capital Management Montpelier, Vermont $1.49B AUM 23.46% 1-Year Est. Return

Boston Family Office's Q3 2020 Portfolio in Review

As of Q3 2020, Boston Family Office held 248 positions worth $1.1B, up 7.1% from $1.03B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Boston Family Office's Q3 2020 filing shows 4 new, 56 increased, 116 reduced and 11 closed positions. Its largest new stake was Relay Therapeutics: 21,121 shares worth $900K. The largest sale was Apple, an estimated $4.51M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q3 2020 buy was Relay Therapeutics: 21,121 shares worth $900K.
  • Boston Family Office added most to Zebra Technologies in Q3 2020, an estimated $2.39M increase.
  • Boston Family Office's biggest Q3 2020 reduction was Apple, cutting an estimated $4.51M.
  • Boston Family Office fully exited ICU Medical in Q3 2020, selling an estimated $829K.
  • Boston Family Office's ten largest holdings make up 29% of its $1.1B portfolio in Q3 2020.
  • Boston Family Office opened 4 new positions and closed 11 in Q3 2020.
  • Boston Family Office's portfolio value rose 7.1% quarter-over-quarter to $1.1B.

Based on Boston Family Office's 13F filing for Q3 2020, filed 10 Nov 2020.